Report
Louis AZAIS
EUR 106.04 For Business Accounts Only

Analyse court terme - BIOMERIEUX : La résistance est atteinte, elle cause le repli.

Le support vient d'être enfoncé, la tendance devient négative puisque nous avons maintenant une succession de sommets et de creux descendants. Le prochain objectif est à 157,20 €. Le niveau d'invalidation est au-dessus de 200,80 €.

Arguments :
- Le support est enfoncé.
- La...
Underlying
BioMerieux SA

Provider
Day By Day
Day By Day

​​DayByDay is an independent research company providing global macro and single stock analysis, recommendation and allocation based purely on behavioural finance methods. Those include long term cycle analysis, sentiment analysis, and technical trigger. DayByDay serves all clients in need of practical and precise publications to make effective market decisions, on any time horizon, from a few hours to a few years.

Analysts
Louis AZAIS

Other Reports on these Companies
Other Reports from Day By Day

ResearchPool Subscriptions

Get the most out of your insights

Get in touch